EDITORIAL
Published on 29 Jul 2022
Editorial: insights in cancer endocrinology 2021
doi 10.3389/fendo.2022.987764
- 1,277 views
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Insights in Cancer Endocrinology: 2021
Insights in Cancer Endocrinology: 2021
20k
Total downloads
66k
Total views and downloads
Articles
MINI REVIEW
Published on 17 Jun 2022
Activation Versus Inhibition of IGF1R: A Dual Role in Breast Tumorigenesis
doi 10.3389/fendo.2022.911079
- 2,305 views
- 6 citations
REVIEW
Published on 16 Jun 2022
Fertility Preservation and Restoration Options for Pre-Pubertal Male Cancer Patients: Current Approaches
doi 10.3389/fendo.2022.877537
- 4,041 views
- 9 citations
ORIGINAL RESEARCH
Published on 03 Jun 2022
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells
doi 10.3389/fendo.2022.867822
- 1,857 views
- 8 citations
ORIGINAL RESEARCH
Published on 25 May 2022
Burden of Prostate Cancer in China, 1990–2019: Findings From the 2019 Global Burden of Disease Study
doi 10.3389/fendo.2022.853623
- 6,874 views
- 26 citations
ORIGINAL RESEARCH
Published on 27 Apr 2022
Is Encapsulated Medullary Thyroid Carcinoma Associated With a Better Prognosis? A Case Series and a Review of the Literature
doi 10.3389/fendo.2022.866572
- 3,695 views
- 4 citations
MINI REVIEW
Published on 05 Apr 2022
New Insights in PRRT: Lessons From 2021
doi 10.3389/fendo.2022.861434
- 10,761 views
- 15 citations
REVIEW
Published on 31 Mar 2022
BRCA1: An Endocrine and Metabolic Regulator
doi 10.3389/fendo.2022.844575
- 7,767 views
- 20 citations
ORIGINAL RESEARCH
Published on 30 Mar 2022
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas
doi 10.3389/fendo.2022.841118
- 1,965 views
- 10 citations
REVIEW
Published on 21 Mar 2022
Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task
doi 10.3389/fendo.2022.840971
- 4,941 views
- 2 citations
ORIGINAL RESEARCH
Published on 21 Mar 2022
VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
doi 10.3389/fendo.2022.854365
- 2,953 views
REVIEW
Published on 11 Feb 2022
New Insights and Emerging Therapeutic Approaches in Prostate Cancer
doi 10.3389/fendo.2022.840787
- 3,683 views
- 8 citations
